drugset / Trial / NCT01803360

Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.

NCT01803360 ↗

Phase 2 Unknown 60 enrolled ASST Gaetano Pini-CTO
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether neridronate is effective in the treatment of pain related to bone marrow oedema in patients with osteoarthritis of the knee.

Timeline

Start
2013-03
Primary completion
2013-07
Completion
2013-09

Outcome

Met primary endpoint

paper the VAS decreased significantly more in the neridronate group [from 59.0 (s.d. 14.7) to 30.4 (s.d. 15.6); -48.4%; P < 0.001]. PMID 25998450 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Neridronate Unknown 100 mg Intravenous

Indications